Aurinia Pharmaceuticals Loses Value Despite Good Financials
Trending News 🌧️ Aurinia Pharmaceuticals Intrinsic Value – Aurinia Pharmaceuticals ($NASDAQ:AUPH), a Canadian biotech, lost 22% of its value pre-market [...]
Aurinia Pharmaceuticals Announces Departure of Chief Medical Officer and Executive Vice President
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) is a Canadian clinical-stage biopharmaceutical company developing novel immunomodulatory therapies to treat autoimmune diseases. [...]
The Insider For Aurinia Pharmaceuticals Bought 5,000 Shares of Stock
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a clinical stage biopharmaceutical company. The company focuses on the business of [...]
Aurinia Pharmaceuticals’ Lupkynis Approved by European Commission for Lupus Nephritis
Trending News ☀️ Aurinia Pharmaceuticals Intrinsic Value – The approval of Lupkynis in the EU triggers a $30 million milestone [...]
